Company PROCEPT BioRobotics Corporation

Equities

PRCT

US74276L1052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-01 pm EDT 5-day change 1st Jan Change
60.56 USD +14.31% Intraday chart for PROCEPT BioRobotics Corporation +15.40% +44.50%

Business Summary

PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). The AquaBeam Robotic System employs a single-use disposable handpiece to deliver the Company’s proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The Company designed Aquablation therapy to deliver effective, safe and durable outcomes for males suffering from lower urinary tract symptoms, (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.

Number of employees: 626

Sales per Business

USD in Million2022Weight2023Weight Delta
Hand Pieces and Other Consumables
51.0 %
32 42.4 % 70 51.0 % +118.51%
System and Rentals
43.3 %
40 53.0 % 59 43.3 % +48.31%
Service
5.7 %
3 4.6 % 8 5.7 % +123.31%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
91.3 %
68 90.3 % 124 91.3 % +83.42%
Non-United States
8.7 %
7 9.7 % 12 8.7 % +64.15%

Managers

Managers TitleAgeSince
Chief Executive Officer 69 20-02-05
Director of Finance/CFO 46 -
Chief Tech/Sci/R&D Officer - 16-05-31
Chief Tech/Sci/R&D Officer 62 22-03-31
Chief Operating Officer 60 21-02-28
Public Communications Contact - 21-01-31
Corporate Officer/Principal - -
General Counsel - 18-04-30
Corporate Officer/Principal 49 19-02-28
General Counsel 45 18-06-30

Members of the board

Members of the board TitleAgeSince
Chairman 72 11-07-31
Director/Board Member 48 20-12-16
Chief Executive Officer 69 20-02-05
Director/Board Member 72 10-11-30
Director/Board Member 46 15-05-31
Director/Board Member 62 21-10-20
Director/Board Member 65 21-12-28
Director/Board Member 51 21-06-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 51,400,156 49,566,738 ( 96.43 %) 0 96.43 %

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
14.45 %
7,361,844 14.45 % 364 M $
CPMG, Inc.
10.46 %
5,328,867 10.46 % 263 M $
Vanguard Fiduciary Trust Co.
8.211 %
4,184,585 8.211 % 207 M $
T. Rowe Price Investment Management, Inc.
7.250 %
3,695,027 7.250 % 183 M $
BlackRock Advisors LLC
6.235 %
3,177,390 6.235 % 157 M $
AllianceBernstein LP
4.035 %
2,056,350 4.035 % 102 M $
Champlain Investment Partners LLC
3.116 %
1,588,039 3.116 % 78 M $
T. Rowe Price International Ltd.
2.954 %
1,505,659 2.954 % 74 M $
Loomis, Sayles & Co. LP
2.584 %
1,316,708 2.584 % 65 M $
1,085,565 2.130 % 54 M $

Company contact information

PROCEPT BioRobotics Corp.

150 Baytech Drive

95134, San Jose

+

http://www.procept-biorobotics.com
address PROCEPT BioRobotics Corporation(PRCT)
  1. Stock Market
  2. Equities
  3. PRCT Stock
  4. Company PROCEPT BioRobotics Corporation